Log in to save to my catalogue

RNA sequencing reveals BMP4 as a basis for the dual-target treatment of diabetic retinopathy

RNA sequencing reveals BMP4 as a basis for the dual-target treatment of diabetic retinopathy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2460764339

RNA sequencing reveals BMP4 as a basis for the dual-target treatment of diabetic retinopathy

About this item

Full title

RNA sequencing reveals BMP4 as a basis for the dual-target treatment of diabetic retinopathy

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Journal of molecular medicine (Berlin, Germany), 2021-02, Vol.99 (2), p.225-240

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Background
Diabetic retinopathy (DR), currently considered as a neurovascular disease, has become the major cause of blindness. More and more scholars believe that DR is no longer just a kind of microvascular disease, but accompanied by retinal neurodegenerative changes. Intravitreal injection of anti-vascular endothelial growth factor (VEGF) dr...

Alternative Titles

Full title

RNA sequencing reveals BMP4 as a basis for the dual-target treatment of diabetic retinopathy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2460764339

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2460764339

Other Identifiers

ISSN

0946-2716

E-ISSN

1432-1440

DOI

10.1007/s00109-020-01995-8

How to access this item